2020
DOI: 10.1016/j.ejmech.2020.112735
|View full text |Cite
|
Sign up to set email alerts
|

Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…In this work, the novel pleuromutilin derivatives were chosen from Ref. [20]. The Initially, the antibacterial activities MIC (μM) are converted to the corresponding pMIC (-logMIC) values, and employed as dependent variable in the QSAR analyses.…”
Section: Datasetmentioning
confidence: 99%
See 2 more Smart Citations
“…In this work, the novel pleuromutilin derivatives were chosen from Ref. [20]. The Initially, the antibacterial activities MIC (μM) are converted to the corresponding pMIC (-logMIC) values, and employed as dependent variable in the QSAR analyses.…”
Section: Datasetmentioning
confidence: 99%
“…Recently, some groups have been endeavoring to synthesize novel pleuromutilin derivatives with improved activities [20][21][22]. However, it is time-consuming and material redundant for the synthesis of range of new derivatives.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Among heterocyclic compounds, pyrimidine derivatives are an important class of compounds with various biological properties, including antibacterial activity against Gram‐positive and Gram‐negative bacteria (Basha & Goudgaon, 2021; Nadar & Khan, 2022). The presence of amino(alkyl) residues in the thiopyrimidine scaffold is useful for obtaining good antimicrobial activity of the compounds (Attia et al., 2014; Fan et al., 2020). Furthermore, thiophenyl‐substituted pyrimidine derivative (F20) shows significant antibacterial activity against Gram‐positive bacteria, which include drug‐resistant bacteria like methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant Enterococcus (VRE) (Fang et al., 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies on the structure-activity relationship (SAR) have shown that the C-14 side chain of pleuromutilin derivatives containing thioether bonds, basic groups, or heterocyclic rings containing polar groups can improve their antibacterial activity 17–23 . In our previous work, some novel pleuromutilin analogues which having a piperazine as linker displayed potent in vitro and in vivo antibacterial activity against S. aureus (ATCC 29213) 20 , 21 .…”
Section: Introductionmentioning
confidence: 99%